Tag: NLRP3 inhibitor

Zydus Advances Phase II Trial of ZYIL1, a Promising NLRP3 Inhibitor, in ALS Patients

by Navneet Arora

October 25, 2023

Zydus Life Sciences has received the green light from the Central Drugs Standard Control Organization (CDSCO), India, to embark on ...

About Us

Unlock success with Biz Iconic—a guide to business, entrepreneurship, and innovation. Stay ahead with insights, trends, and success stories from visionary leaders.

About Us
Contact Us
Privacy Policy
Terms & Conditions
Disclaimer

No Result

View All Result

Home
Featured
Business
Entertainment
Tech
Lifestyle
Sports
India
World
Advertise
Internship
Learn More

Tag: NLRP3 inhibitor

Zydus Advances Phase II Trial of ZYIL1, a Promising NLRP3 Inhibitor, in ALS Patients

Most Recent

Smita Sabharwal’s X Post Sparks Row Amid Puja Khedkar Fraud Controversy

Watch: ‘Modern Masters’ Trailer Drops, To Premiere on Netflix on August 2

Top 10 World’s Happiest Countries In 2024

Ram Charan To Be Awarded the Ambassador for Indian Art and Culture at IFFM 2024

Alfonso Cuarón to Receive Lifetime Achievement Award at Locarno Film Festival

‘Raayan’ Trailer Out: Dhanush’s 50th Film Hits Theatres on July 26

PM Modi Reaches 100 Million Followers on X

Watch: The Perfect Couple Trailer, Bollywood Actor Ishaan Khatter Joins the Cast

Biden’s NATO Summit Slip-Ups Fuel Concerns About his Leadership

Anurag Kashyap Presents ‘Footage’, Directed by Saiju Sreedharan

About Us

Follow Us